Mesenchymal Stem Cells Market Scope
Mesenchymal stem cells help to replace or repair damaged tissue. The mesenchymal stem cells market is expected to grow in the future due to the rising aging population and an increasing number of chronic disease and bone and cartilage disease patients.
The market study is being classified by Type (MSC-BM, MSC-UC, MSC-AT and Others), by Application (Cell Differentiation and Gene Regulation, Gene Therapy and Transplantation, Cell-based Screening Assays and Others) and major geographies with country level break-up.
The global mesenchymal stem cells market is fragmented and key players in the market are introducing innovative products along with targeting partnerships and collaborations. Global players are entering new markets in developing regions to expand their customer base and strengthen market presence. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Mesenchymal Stem Cells market throughout the predicted period.
Lonza Group (Switzerland), Thermo Fisher Scientific (United States), Bio-Techne Corporation (United States), Miltenyi Biotec (Germany), PromoCell GmbH (Germany), Irvine Scientific (United States), Axol Bioscience (United Kingdom), STEMCELL Technologies Inc.(Canada), Biological Industries (Israel) and Mesoblast Limited (Australia) are some of the key players profiled in the study.
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Mesenchymal Stem Cells market by Type, Application and Region.
On the basis of geography, the market of Mesenchymal Stem Cells has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In Sept 2019, A new study released in STEM CELLS demonstrates that mesenchymal stromal cells (MSCs) expanded from adipose tissue (ASC) outperform those expanded from bone marrow (BM-MSCs). Importantly, while several previous studies have compared the performance of BM-MSCs versus ASCs, this is the first to pair MSCs from the same donor to show that tissue, rather than donor origin, is the functional predictor.
Market Trend
- Rising Innovation related to Mesenchymal Stem Cells Products
Market Drivers
- Growing Geriatric Population
- Rising Number of Patients of Chronic Diseases, Bone and Cartilage Diseases, and Autoimmune Diseases
Opportunities
- Growth in Government Support ion form of Regulations and Funding
- Developing Healthcare Infrastructure in Developing Countries
Restraints
- Lack of Therapeutic Advancement in Underdeveloped Countries
Challenges
- Some Adverse Effects Transplanted Mesenchymal Stem Cells
Key Target Audience
Mesenchymal Stem Cells Therapeutics, Healthcare industry, Potential Investors and Research and Development Organisation
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase